Dr. Daniel Adam Balikov, MD, PhD

Dr. Balikov practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Balikov's NPI, 1215598024, was assigned on June 24, 2019. Dr. Balikov graduated from Vanderbilt University School Of Medicine in 2019. Dr. Balikov holds Florida license ME161907.

Dr. Balikov's primary practice is Northwestern Medical Group, at 675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611. The practice phone is (312) 664-3278.

Dr. Balikov's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Balikov is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Balikov to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balikov practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Balikov's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Balikov is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Balikov's licenses on file in 2 states: Florida and Michigan.

CMS data shows 50 Medicare services from Dr. Balikov across 2 procedure codes in 2024, for 80 Medicare patients. Medicare paid $3,207 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Balikov in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Balikov's median patient age at 71, with 58% women.

In 2024, Dr. Balikov wrote 181 Medicare Part D claims for 99 patients. 73% of them were for generic drugs. CMS names the drug for 102 of them, across 5 drugs with 11 or more claims each, at $2,090 in total drug cost. In 2023, CMS named 347 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Balikov for performance year 2024, reported as part of a group. Dr. Balikov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 39 papers to Dr. Balikov, published from 2015 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Cell Differentiation, Cells, Cultured and Mesenchymal Stem Cells. Dr. Balikov has published most often in Int J Mol Sci. Dr. Balikov's most frequent co-authors are Brian James O'Grady, MD, Hakan Demirci, MD and Christy McCuen Guth, MD.

CMS Open Payments shows 20 general payments to Dr. Balikov from 9 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 54% of the total. Alcon Laboratories Inc paid the most, $1,330.

Dr. Balikov graduated from Vanderbilt University School Of Medicine in 2019.

Dr. Balikov is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.